An elderly patient with fluoroquinolone-associated achilles tendinitis

American Journal Geriatric Pharmacotherapy

Volumn 6, Issue 5, 2008, Pages 264-268

  Damuth, Emily ^a   Heidelbaugh, Joel ^a   Malani, Preeti N ^a,b   Cinti, Sandro K ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Achilles tendinitis; ciprofloxacin; fluoroquinolone; tendinitis

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CREATININE; FUROSEMIDE; HEMOGLOBIN; METOPROLOL; MEVINOLIN; NITROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALBUTAMOL; TERAZOSIN;

ACHILLES TENDINITIS; AGED; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSURIA; ERYTHROCYTE COUNT; ESCHERICHIA COLI; EVENING DOSAGE; FLANK PAIN; HEEL PAIN; HEMOGLOBIN DETERMINATION; HUMAN; IMPAIRED BLADDER EMPTYING; KINESIOTHERAPY; LABORATORY TEST; LEUKOCYTE COUNT; MALE; PAIN ASSESSMENT; PHYSICAL EXAMINATION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINARY TRACT INFECTION; WEIGHT BEARING;

AGED; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; HUMANS; KIDNEY DISEASES; MALE; RISK FACTORS; TENDINOPATHY; URINARY TRACT INFECTIONS;

EID: 58249116662     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2008.11.002     Document Type: Article

References (16)

1. Stahlmann R., and Lode H. Fluoroquinolones in the elderly: Safety considerations. Drugs Aging 20 (2003) 289-302
2. van der Linden P.D., van de Lei J., Nab H.W., et al. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 48 (1999) 433-437
3. Corrao G., Zambon A., Bertù L., et al. Evidence of tendinitis provoked by fluoroquinolone treatment: A casecontrol study. Drug Saf 29 (2006) 889-896
4. US Food and Drug Administration (FDA). FDA News. FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs: Seeks to Strengthen Warnings Concerning Increased Risk of Tendinitis and Tendon Rupture [FDA Web site].
5. http://www.fda.gov/bbs/topics/NEWS/2008/NEW01858.html Accessed July 15, 2008
6. Mahoney P.G., James P.D., Howell C.J., and Swannell A.J. Spontaneous rupture of the Achilles tendon in a patient with gout. Ann Rheum Dis 40 (1981) 416-418
7. Khaliq Y., and Zhanel G.G. Fluoroquinolone-associated tendinopathy: A critical review of the literature. Clin Infect Dis 36 (2003) 1404-1410
8. Yu C., and Giuffre B.M. Achilles tendinopathy after treatment with fluoroquinolone. Australas Radiol 49 (2005) 407-410
9. van der Linden P.D., van Puijenbroek E.P., Feenstra J., et al. Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum 45 (2001) 235-239
10. Marti H.P., Stoller R., and Frey F.J. Fluoroquinolones as a cause of tendon disorders in patients with renal failure/renal transplants. Br J Rheumatol 37 (1998) 343-344
11. Haddow L.J., Chandra Sekhar M., Hajela V., and Gopal Rao G. Spontaneous Achilles tendon rupture in patients treated with levofloxacin. J Antimicrob Chemother 51 (2003) 747-748
12. Mathis A.S., Chan V., Gryszkiewicz M., et al. Levofloxacin-associated Achilles tendon rupture. Ann Pharmacother 37 (2003) 1014-1017
13. Leibovitz E. The use of fluoroquinolones in children. Curr Opin Pediatr 18 (2006) 64-70
14. The American Academy of Pediatrics. The use of systemic fluoroquinolones. Pediatrics 118 (2006) 1287-1292
15. Shortt P., Wilson R., and Erskine I. Tendinitis: The Achilles heel of quinolones!. Emerg Med J 23 (2006) e63
16. Muzi F., Gravante G., Tati E., and Tati G. Fluoroquinolones-induced tendonitis and tendon rupture in kidney transplant recipients: 2 Cases and a review of the literature. Transplant Proc 39 (2007) 1673-1675